New York Times: It’s Time for a Reckoning on Medical Devices
The New York Times recently published a comprehensive look at how patients suffer when companies and regulators fail to effectively screen or monitor defective medical devices on the market. In the past decade, nearly two million injuries and more than 80,000 deaths have been linked to faulty medical devices, many approved...
Continue ReadingBayer Reeling After Spending Summer in Spotlight for Dangerous Products
[video src="https://www.corywatson.com/wp-content/uploads/2018/07/Documentary-_The-Bleeding-Edge_-shines-light-on-medical-device-risks.mp4" /] Bayer AG faces more than 8,700 plaintiffs across the U.S. alleging that recently-acquired Monsanto’s glyphosate-based weed killers such as Roundup® and Ranger Pro® cause cancer. The international pharmaceutical and agricultural giant recently acquired Monsanto in a $63 billion deal completed in June 2018, taking on a daunting...
Continue ReadingNetflix Documentary ‘The Bleeding Edge’ Exposes Dangerous Medical Devices
From birth-control devices to hip implants, the majority of medical devices hit the market without proper testing. Sometimes these untested devices, meant to improve lives, ruin them instead. Pharmaceutical and medical device companies make billions. Patients often pay with their health. These are the horrors exposed in the terrifying new documentary “The...
Continue ReadingEssure Permanent Birth Control Dangers Featured on Good Morning America
As featured today on “Good Morning America,” Bayer Pharmaceuticals announced that it will no longer sell the controversial permanent birth control implant Essure starting at the end of this year. The move follows thousands of lawsuits, as women stand up to “Big Pharma” and hold corporations responsible for serious injuries such...
Continue ReadingBayer Discontinues Controversial Essure® Permanent Birth Control
Today, pharmaceutical giant Bayer announced it was discontinuing sales of its Essure® birth control device, no longer selling or distributing the product after December 31, 2018. This announcement comes after the U.S. Food & Drug Administration (FDA) took an extraordinary step in April by limiting sales to doctors who ensured that...
Continue Reading